Recent patents on live bacteria and their products as potential anticancer agents

Arsenio M Fialho1, Nuno Bernardes, Ananda M Chakrabarty

  • 1Department of Microbiology & Immunology, University of Illinois College of Medicine, 835 South Wolcott Avenue, Chicago, IL 60612, USA. afialho@ist.utl.pt

Insights

This review covers patents since 2007 on using live or attenuated bacteria and microbial products as anticancer agents. It summarizes key findings from published and issued patents on these novel cancer therapies.

Area of Science:

  • Biotechnology and Microbiology
  • Cancer Research and Therapeutics
  • Intellectual Property in Medicine

Background:

  • The use of microbial agents in medicine has a long history.
  • Recent advancements have renewed interest in bacteria and their products for therapeutic applications.
  • Cancer remains a significant global health challenge, driving the search for novel treatment strategies.

Purpose of the Study:

  • To comprehensively review patents published or issued since 2007.
  • To cover live or attenuated bacteria as potential anticancer agents.
  • To summarize microbial products, including toxins, enzymes, antibiotics, proteins, peptides, and small molecules, patented for anticancer use.

Main Methods:

  • Systematic literature search of patent databases.
  • Analysis of patent filings related to microbial anticancer agents.
  • Categorization of patents based on the type of microbial product or bacterial strain.
  • Summary of the main contents and claims within selected patents.

Main Results:

  • A significant number of patents have been issued/published since 2007.
  • Patents cover diverse microbial entities, including whole bacteria and various secreted or intracellular products.
  • The reviewed patents highlight a growing interest in microbial-based cancer therapies.
  • Specific examples of patented bacterial strains and microbial products are detailed.

Conclusions:

  • Patents demonstrate substantial innovation in microbial-based anticancer therapies.
  • Live/attenuated bacteria and microbial products represent a promising area for future cancer drug development.
  • Further research and clinical translation are warranted based on patent trends.

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...